Oncotarget

Research Papers:

Good syndrome presenting with CD8+ TCell large granular lymphocyte leukemia

PDF  |  Full Text  |  How to cite

Oncotarget. 2015; 6:36577-36586. https://doi.org/10.18632/oncotarget.5369

Metrics: PDF 3123 views  |  Full Text 3303 views

Caroline Caperton1, Sudhanshu Agrawal1, Sudhir Gupta1

1Program in Primary Immunodeficiency and Aging, Division of Basic and Clinical Immunology, University of California at Irvine, Irvine, California, USA

Correspondence to:

Sudhir Gupta, e-mail: [email protected]

Keywords: IFNgamma, PD-1, ICOS, memory T, granzyme

Received: June 24, 2015     Accepted: September 17, 2015     Published: September 29, 2015

ABSTRACT

Good Syndrome is an adult-onset combined immunodeficiency defined by hypogammaglobulinemia, low or absent number of B cells, T cell deficiency and thymic tumor. We have characterized CD8+ T cells from a patient with Good syndrome that presented with CD8+T-cell large granular lymphocytic leukemia (LGL). Characterization of peripheral blood CD8+ T cells revealed that majority of CD8+ T cells were terminally differentiated effector memory phenotype (TEMRA; CD8+CCR7-CD45RA+), and were PD-1high (CD279), ICOSlow (CD278), and granzymehigh. Almost all CD8+ T cells were IFN-γ+. CD8 Treg (CD8+CD183+CCR7+CD45RA-) were decreased. TEMRA phenotype along with CD279high, demonstrates that these are exhausted CD8+ T cells. This phenotype along with CD278low may also explain severe T cell functional deficiency in our patient. In the present patient, T-LGL appears to be a clonal expansion of CD279+granzyme+IFN-γ+CD8+TEMRA cells. To best of our knowledge this is the first case of CD8+T-cell LGL leukemia associated with Good syndrome.